Price T Rowe Associates Inc Vera Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,939,109 shares of VERA stock, worth $167 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,939,109
Previous 3,620,135
8.81%
Holding current value
$167 Million
Previous $131 Million
32.93%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$182 Million2.87% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$141 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$125 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$118 Million11.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.58MShares$109 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.14B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...